Frontlight ResearchEarly access
Trial site
Allina Health Cancer Institute
- 1running trial
- 8closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer2 trials
- Colorectal cancer2 trials
- Lung cancer2 trials
- Melanoma2 trials
- Metastatic breast cancer2 trials
- Triple-negative breast cancer2 trials
- Acute myeloid leukaemia1 trial
- Cervical cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- and 6 more
- Phase
- Phase 23 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 31 trial
- Status
- Completed6 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Seagen Inc.2 trials
- Adela, Inc1 trial
- Freenome Holdings Inc.1 trial
- Gilead Sciences1 trial
- Pacific Edge Limited1 trial
- and 3 more
Running trials
Closed trials
Recruiting
Recruiting
Terminated
Completed
Completed
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer
Completed
Prevention of Colorectal Cancer Through Multiomics Blood Testing
Completed
STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026